Search - tctmd.com

Displaying 21 - 40 of 88

Sort: Relevancy | Date

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

Presentation AHA 2024

Randomized Study Comparing PK/PD Properties of a Novel Intranasal Formulation of Bumetanide to Oral and IV Formulations

Presenter: Daniel Bensimhon

November 18, 2024

Presentation AHA 2024

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Presenter: Sanjit S Jolly

November 17, 2024

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation ESC 2024

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

Presenter: Pardeep S. Jhund

September 01, 2024

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

Presentation THT 2024

PH-HFpEF: Levosimendan

Presenter: Sanjiv J. Shah

March 06, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT 2024

Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

Presenter: Palak Shah

March 05, 2024

Presentation THT 2024

Continue MCS for Another 14 days

Presenter: Manreet Kanwar

March 04, 2024

Presentation THT 2024

List for Urgent Transplant

Presenter: Tariq Ahmad

March 04, 2024

Presentation THT 2024

A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery

Presenter: Elena M. Donald

March 04, 2024

Presentation THT 2024

Cardiac Recovery in Response to Temporary Mechanical Circulatory Support

Presenter: Jane E. Wilcox

March 04, 2024

Presentation THT 2024

Cardiac Recovery in Response to GDMT

Presenter: Andreas Kalogeropoulos

March 04, 2024

Presentation THT 2024

Myocardial Recovery at the Level of the Single Myocyte

Presenter: Veli K. Topkara

March 04, 2024

Presentation THT 2024

Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support

Presenter: Emma Birks

March 04, 2024

Presentation THT 2024

Contemporary Pharmacological Therapies for Acute Heart Failure

Presenter: Wilfried Mullens

March 04, 2024

Presentation THT 2024

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

Presenter: Benjamin Hibbert

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Advertisement

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Randomized Study Comparing PK/PD Properties of a Novel Intranasal Formulation of Bumetanide to Oral and IV Formulations

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

PH-HFpEF: Levosimendan

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

Continue MCS for Another 14 days

List for Urgent Transplant

A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery

Cardiac Recovery in Response to Temporary Mechanical Circulatory Support

Cardiac Recovery in Response to GDMT

Myocardial Recovery at the Level of the Single Myocyte

Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support

Contemporary Pharmacological Therapies for Acute Heart Failure

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content